Maciej Lesiak

Author PubWeight™ 39.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention 2015 4.00
2 [Bivalirudine use in the acute myocardial infarction in patients undergoing percutaneous coronary interventions: consensus statement of experts from the Cardiovascular Pharmacotherapy Working Group and the Association on Cardiovascular Interventions of the]. Kardiol Pol 2014 2.02
3 Twelve-month results of a paclitaxel releasing balloon in patients presenting with in-stent restenosis First-in-Man (PEPPER) trial. Cardiovasc Revasc Med 2012 1.48
4 Effect of new method of intracoronary adenosine injection during primary percutaneous coronary intervention on microvascular reperfusion injury - clinical outcome and 1-year follow-up. Cardiology 2013 1.44
5 First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results. Kardiol Pol 2012 1.41
6 Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis. Catheter Cardiovasc Interv 2011 1.41
7 Primary percutaneous angioplasty, thrombolysis and conservative treatment in low-risk patients with ST-elevation myocardial infarction: effects on short- and long-term mortality. Kardiol Pol 2012 1.39
8 Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation. Eur Heart J 2009 1.09
9 Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective. EuroIntervention 2015 1.04
10 Apoptosis as a mechanism for the elimination of cardiomyocytes after acute myocardial infarction. Am J Cardiol 2010 0.96
11 Effect of impaired myocardial reperfusion on left ventricular remodeling in patients with anterior wall acute myocardial infarction treated with primary coronary intervention. Am J Cardiol 2006 0.95
12 Clinical pharmacokinetics of clopidogrel and its metabolites in patients with cardiovascular diseases. Clin Pharmacokinet 2014 0.94
13 Transcatheter aortic valve implantation: the new option for high-risk patients with aortic stenosis. Cardiol J 2011 0.90
14 New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 2011 0.86
15 [New model of the optimal oral antiplatelet treatment in patients with the ST-segment elevation myocardial infarction in Poland. Polish Cardiac Society statement]. Kardiol Pol 2011 0.85
16 Short- and long-term mortality in patients with ST-elevation myocardial infarction treated with different therapeutic strategies. Results from WIelkopolska REgional 2002 Registry (WIRE Registry). Kardiol Pol 2008 0.85
17 Acute myocardial infarction and rapid development of coronary aneurysms in a young woman--unusual presentation of Takayasu arteritis? Can J Cardiol 2007 0.84
18 Placement of Tryton Side Branch Stent only; a new treatment strategy for Medina 0,0,1 coronary bifurcation lesions. Catheter Cardiovasc Interv 2013 0.82
19 Setaria tundra in roe deer (Capreolus capreolus)--new findings in Poland. Ann Parasitol 2013 0.81
20 Relationship between tissue reperfusion and postinfarction left ventricular remodelling in patients with anterior wall myocardial infarction treated with primary coronary angioplasty. Kardiol Pol 2006 0.81
21 Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population. EuroIntervention 2012 0.80
22 Clinical outcomes after final kissing balloon inflation compared with no final kissing balloon inflation in bifurcation lesions treated with a dedicated coronary bifurcation stent. Heart 2014 0.80
23 Chronic infarct-related artery occlusion is associated with a reduction in capillary density. Effects on infarct healing. Eur J Heart Fail 2005 0.80
24 [Interventional cardiology in Poland in the year 2012. Summary report of the Association of Cardiovascular Interventions of the Polish Cardiac Society]. Kardiol Pol 2013 0.79
25 Relations of diabetes mellitus, microvascular reperfusion and left ventricular remodelling in patients with acute myocardial infarction treated with primary coronary intervention. Kardiol Pol 2013 0.79
26 Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial. EuroIntervention 2012 0.79
27 Intracoronary adenosine administered during aortocoronary vein graft interventions may reduce the incidence of no-reflow phenomenon. A pilot randomised trial. Kardiol Pol 2013 0.78
28 Fracture of a carotid stent and restenosis of common carotid artery. Arch Med Sci 2013 0.78
29 Role of adenosine as an adjunct therapy in the prevention and treatment of no-reflow phenomenon in acute myocardial infarction with ST segment elevation: review of the current data. Kardiol Pol 2013 0.78
30 Does the influence of obesity on prognosis differ in men and women? A study of obesity paradox in patients with acute coronary syndrome. Kardiol Pol 2015 0.78
31 Temporal trends and patterns in percutaneous treatment of coronary artery disease in Poland in the years 2005-2011. Kardiol Pol 2015 0.78
32 Effect of microvascular reperfusion on prognosis and left ventricular function in anterior wall myocardial infarction treated with primary angioplasty. Int J Cardiol 2006 0.78
33 Comparison of angiographically guided direct stenting technique with direct stenting and optimal balloon angioplasty guided with intravascular ultrasound. The multicenter, randomized trial results. Am Heart J 2007 0.78
34 Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score. EuroIntervention 2017 0.78
35 Exercise capacity, arrhythmic risk profile, and pulmonary function is not influenced by intracoronary injection of bone marrow stem cells in patients with acute myocardial infarction. Int J Cardiol 2011 0.77
36 Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry. EuroIntervention 2013 0.77
37 12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry. EuroIntervention 2017 0.77
38 Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry. EuroIntervention 2016 0.77
39 Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies. EuroIntervention 2013 0.77
40 A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry. EuroIntervention 2012 0.76
41 Postconditioning reduces enzymatic infarct size and improves microvascular reperfusion in patients with ST-segment elevation myocardial infarction. Cardiology 2014 0.76
42 Impact of atrial remodeling on heart rhythm after radiofrequency ablation and mitral valve operations. Ann Thorac Surg 2012 0.76
43 Effect of heparin on blood vascular endothelial growth factor levels in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2006 0.75
44 [New model of the optimal oral antiplatelet treatment in patients with the ST-segment elevation myocardial infarction in Poland - authors' reply]. Kardiol Pol 2012 0.75
45 Transcatheter aortic valve implantation. Expert Consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of Cardio-Thoracic Surgeons, approved by the Board of the Polish Cardiac Society…. Kardiol Pol 2017 0.75
46 [Guidelines of the Association of Cardiovascular Interventions of the Polish Cardiac Society for certification of coronary diagnosts and percutaneous coronary intervention operators and invasive cardiology centers in Poland]. Kardiol Pol 2013 0.75
47 [Current status of drug-eluting stents and drug-eluting balloons in patients with stable coronary artery disease--an expert consensus document of the Association for Percutaneous Cardiovascular Interventions and Polish Cardiac Society]. Kardiol Pol 2011 0.75
48 Acute myocardial infarction in an 80 year-old woman caused by left main occlusion with concomitant chronic total occlusions of right and left coronary artery: successful treatment with percutaneous revascularization. Cardiol J 2009 0.75
49 [Does the treatment delay influence reperfusion efficacy and short- and long-term left ventricular function in patients with anterior myocardial infarction treated with primary coronary angioplasty?]. Pol Arch Med Wewn 2004 0.75
50 [Value of ST-segment elevation resolution after primary coronary angioplasty in predicting early and late left ventricular function in patients with anterior acute myocardial infarction]. Pol Merkur Lekarski 2005 0.75
51 Balloon aortic valvuloplasty - ups and downs - are we facing a procedure comeback? Kardiol Pol 2015 0.75
52 [Left ventricle hypertrophy following myocardial infarction. Morphometric evaluation of the infarcted region and the free wall of the left ventricle]. Pol Arch Med Wewn 2004 0.75
53 Lessons from the GHOST-EU registry. EuroIntervention 2015 0.75
54 The new generation is coming. Percutaneous implantation of the fully repositionable Lotus® aortic valve prosthesis: the first Polish experience. Kardiol Pol 2014 0.75
55 [Greater Poland program for treating acute coronary syndromes]. Kardiol Pol 2003 0.75
56 Under pressure closure of atrial septal defect type II in a patient with pulmonary hypertension. Kardiol Pol 2019 0.75
57 Stepwise optimisation of balloon pulmonary angioplasty in a patient with severe non-operable chronic thromboembolic pulmonary hypertension. EuroIntervention 2017 0.75
58 [Left ventricular remodelling and rebuilding of the infarcted area. Morphometric evaluation of the relationships between left ventricular mass, myocyte diameter, capillary density and fibrosis]. Pol Arch Med Wewn 2006 0.75
59 Simultaneous occlusion of 2 coronary arteries--a rare cause of cardiogenic shock. Am J Emerg Med 2009 0.75
60 Thrombocytosis as a potential cause of a very late stent thrombosis in the left main coronary artery. Kardiol Pol 2013 0.75
61 [Bioresorbable scaffolds in the treatment of coronary artery disease. Expert consensus statement of the Association of Cardiovascular Interventions of the Polish Cardiac Society (ACVI PCS)]. Kardiol Pol 2017 0.75
62 Endothelial cell growth response to stimulation with serum from patients with acute ST-elevation myocardial infarction. Int J Cardiol 2012 0.75
63 Short and mid-term outcome of transcatheter aortic valve implantation in patients with advanced age. Cardiol J 2016 0.75
64 Hormonalna terapia zastępcza a choroby układu sercowo-naczyniowego. Ginekol Pol 2016 0.75
65 Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions. JACC Cardiovasc Interv 2017 0.75
66 Significant stenosis of the left anterior descending artery in a young woman without cardiovascular risk and with above-average physical activity. Kardiol Pol 2017 0.75
67 Anti-aggregation therapy in patients with acute coronary syndrome - recommendations for medical emergency teams. Experts' standpoint. Kardiol Pol 2017 0.75
68 Left ventricular noncompaction cardiomyopathy with severe coronary artery disease in a young patient with familial hypercholesterolemia. Pol Arch Intern Med 2017 0.75
69 First heart sound and opening snap in patients with mitral valve disease. Phonocardiographic and pathomorphologic study. Int J Cardiol 2007 0.75
70 Impact of the presence of chronically occluded coronary artery on long-term prognosis of patients with acute ST-segment elevation myocardial infarction. Cardiol J 2016 0.75
71 [Postconditioning - can the modified reperfusion improve the results of primary coronary angioplasty?]. Kardiol Pol 2012 0.75
72 Prognostic value of angiographic markers of myocardial reperfusion in patients treated with primary coronary angioplasty for anterior wall acute myocardial infarction. Kardiol Pol 2004 0.75
73 Additional side branch stent placement in patients with long side branch lesions treated with the Tryton dedicated bifurcation side branch stent. Int J Cardiol 2013 0.75
74 [From positive remodelling to coronary artery ectasia. Is coronary artery aneurysm a benign form of coronary disease?]. Kardiol Pol 2009 0.75
75 Optical coherence tomography reveals the mechanisms of balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension. Cardiol J 2017 0.75
76 [Invasive treatment strategies in patients with myocardial infarction in Poland]. Kardiol Pol 2010 0.75